Tierra Biosciences offers protein synthesis services using an AI-powered platform, enabling custom protein synthesis and high-throughput data generation.

Tierra Biosciences

Google Maps

Microsoft Exchange Online

Office 365 Mail

GStatic Google Static Content

Google Maps API

Squarespace Hosted

Google Maps for Work

Google DNS

Google Cloud DNS

Chief Executive Officer

Michael Nemzek

Co Founder, CSO

Zachary Sun

Associate Product Manager

Alexis Jacobs

Scientist

Ben Mohr

Associate Scientist

Brenda Cruz

Senior Scientist

Diana Koulechova

Strategic Advisor

Jeff Kim

Scientist, Molecular Biology

Nathan Raynard

Engineering

Oliver Kilian

Associate Automation Engineer

Paul Bisesi

Corinna X. Chen

Louis Metzger

Jonathan Burbaum

Co-founder & CSO

Fred Kittler

Director

Ahmed Qureshi

Head of Business Development & Operations

Richard Murray

Co-Founder

California Companies With Less Than $50M in Revenue (Top 10K)

West Coast Companies With More Than 10 Employees (Top 10K)

San Francisco Bay Area Early Stage Companies With More Than 10 Employees

San Francisco Bay Area Startups Founded in 2015

Tierra Biosciences is an operator of a synthetic biology company intended to accelerate the pace of discovery to enable the next generation of bioengineered products. The company's protein platform leverages cell-free protein production and artificial intelligence and couples high-throughput protein manufacturing with the simplicity of e-commerce.

Material Impact

Series A - Tierra Biosciences

Creative Ventures

Seed Round - Tierra Biosciences

Fifty Years

National Science Foundation

Grant - Tierra Biosciences

Computer and Software Services and Scientific Services

San Leandro

California

United States

North America

Tierra Biosciences on LinkedIn: #geneediting #artificialintelligence #crispr #proteinsynthesis

Tierra Biosciences nabs $11M to create new AI-guided proteins

Tierra raises $11.4 in Series A round for predictive AI protein maker

Tierra Biosciences: $11.4 Million Raised To Advance Cell-Free Protein Production Platform

Tierra Biosciences Secures $11.4M Series A Funding Round Led by Material Impact

Tierra Biosciences raises $11.4m series A to expand designer protein-to-order platform

Tierra Biosciences Closes $11.4M Series A Funding for Cell-Free Protein Platform

Tierra Biosciences Raises $11.4M in Series A Funding

A platform offering rapid access to a wide variety of proteins, including those difficult to produce in common lab cells, using AI-driven computational insights and cell-free expression technology.

Service for producing, testing, and validating hundreds of protein designs rapidly, catering to needs from microgram to gram scale.

Enables rapid synthesis of proteins from digital sequences, facilitating faster research and development cycles.

Supports the production of diverse antibody modalities, including nanobodies, scFvs, and BiTEs, using a cell-free system optimized for biologics.

Utilizes cell-free systems to overcome limitations of traditional cellular expression, especially for toxic or difficult-to-express proteins.

Allows for the combinatorial testing of enzymes and conditions to optimize or identify pathways for product yield improvement.

Tierra Biosciences specializes in protein synthesis on-demand, providing a platform that enables users to input amino acid sequences and receive purified proteins.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 24, 2024 6:13 PM	33210411
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 24, 2024 6:13 PM	23b8b82c
crunchbase trigger	general	Nov 25, 2024 9:09 AM	413c54d6
crunchbase profile	general	Nov 25, 2024 9:16 AM	cc9f099c
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 1:59 PM	708468e8
peers	general	Oct 24, 2024 6:13 PM	bba2b9dc
news basic	general	Oct 24, 2024 6:13 PM	dfe7ed9c
bundesanzeiger	filings
financials download nd	financials
private financials	financials

TIER

COM:TIERRABIOSCIENCES

Tierra Biosciences